Scientists have identified a microRNA in obese mouse mothers that may increase the odds of liver cancer in their offspring throughout multiple generations, report scientists in the Journal of Hepatology. Amsterdam, June 25, 2020 – Scientists recognise the connection between…
EASL has been actively working to beat liver disease, including NAFLD & NASH, through its schools and key event, the NAFLD Summit. EASL has also developed a Policy Statement on the measures required to prevent and treat this common progressive…
Women with non-alcoholic fatty liver disease (NAFLD) should receive preconception counselling on increased maternal and infant risks, while pregnant mothers may benefit from evaluation by a high-risk obstetrics team, recommend scientists in the Journal of Hepatology. Oxford, June 9, 2020…
Be a part of this innovative and engaging digital event for the liver community to connect and learn via cutting-edge content. Enjoy three days of immersive and lively exchanges at the Digital International Liver Congress™ 2020 from 27 to 29…
The EASL members' General Assembly, usually held within the framework of the International Liver Congress™, will take place as an online meeting on Monday, 29 June 2020 at 17:00–19:00 CET. The General Assembly is a key opportunity for EASL members…
A new international study has found increased mortality rates from COVID-19 among people with chronic liver disease and cirrhosis and has called for patients with worsening liver function to be tested for coronavirus. The researchers, led by teams at Oxford…
In a webinar jointly run by EASL and the World Health Organization (WHO), virology and hepatology experts compared strategies in coping during the current pandemic. They described a rise in innovative, cooperative mitigating approaches, but noted that essential hepatitis and…
